HK1076735A1 - Antigen-specific ige antibody production inhibitors - Google Patents
Antigen-specific ige antibody production inhibitorsInfo
- Publication number
- HK1076735A1 HK1076735A1 HK05108838A HK05108838A HK1076735A1 HK 1076735 A1 HK1076735 A1 HK 1076735A1 HK 05108838 A HK05108838 A HK 05108838A HK 05108838 A HK05108838 A HK 05108838A HK 1076735 A1 HK1076735 A1 HK 1076735A1
- Authority
- HK
- Hong Kong
- Prior art keywords
- antibody production
- ige antibody
- antigen
- specific ige
- production inhibitors
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/40—Transferrins, e.g. lactoferrins, ovotransferrins
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/66—Phosphorus compounds
- A61K31/661—Phosphorus acids or esters thereof not having P—C bonds, e.g. fosfosal, dichlorvos, malathion or mevinphos
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
- A61K31/7052—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides
- A61K31/706—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/04—Immunostimulants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Immunology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Epidemiology (AREA)
- Oncology (AREA)
- Communicable Diseases (AREA)
- Virology (AREA)
- Zoology (AREA)
- Gastroenterology & Hepatology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Pulmonology (AREA)
- Molecular Biology (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Coloring Foods And Improving Nutritive Qualities (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
Abstract
Mammalian (including human) IgE antibody production inhibitors and immunomodulatory compositions containing as the active ingredient lactoferrin (LF) or its hydrolyzate; and IFN- gamma production potentiators containing LF or its hydrolyzate and ceramides.
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2000005480 | 2000-01-14 |
Publications (1)
Publication Number | Publication Date |
---|---|
HK1076735A1 true HK1076735A1 (en) | 2006-01-27 |
Family
ID=18534145
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
HK05108838A HK1076735A1 (en) | 2000-01-14 | 2005-10-06 | Antigen-specific ige antibody production inhibitors |
Country Status (6)
Country | Link |
---|---|
JP (1) | JP4787445B2 (en) |
CN (2) | CN100384472C (en) |
AU (1) | AU782539B2 (en) |
HK (1) | HK1076735A1 (en) |
NZ (1) | NZ519957A (en) |
WO (1) | WO2001051079A1 (en) |
Families Citing this family (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2004052281A2 (en) * | 2002-12-06 | 2004-06-24 | Agennix Incorporated | Oral lactoferrin in the treatment of sepsis |
JP2005350452A (en) * | 2004-05-14 | 2005-12-22 | Meiji Milk Prod Co Ltd | COMPOSITION HAVING IgE PRODUCTION-SUPPRESSING ACTIVITY AND METHOD FOR SUPPRESSING IgE PRODUCTION |
JP5061143B2 (en) * | 2009-03-12 | 2012-10-31 | 株式会社クロイスターズ | Topical skin preparation |
Family Cites Families (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR2626472B1 (en) * | 1988-02-02 | 1991-06-14 | Roussel Uclaf | USE OF MILK PROTEINS FOR THE MANUFACTURE OF AN ANTI-VIRAL DRUG |
JPH0559081A (en) * | 1991-08-29 | 1993-03-09 | Kirin Brewery Co Ltd | New sphingoglycolipid, its production and use |
US5936076A (en) * | 1991-08-29 | 1999-08-10 | Kirin Beer Kabushiki Kaisha | αgalactosylceramide derivatives |
FR2728793A1 (en) * | 1994-12-28 | 1996-07-05 | Oreal | Compsns. for treating sensitive skin |
JP3888707B2 (en) * | 1996-01-22 | 2007-03-07 | 森永乳業株式会社 | Antiangiogenic agent |
DE19602108A1 (en) * | 1996-01-22 | 1997-07-24 | Beiersdorf Ag | Substances effective against bacteria, parasites, protozoa, mycota and viruses |
TW480282B (en) * | 1996-04-24 | 2002-03-21 | Ren Wen Corp | Recombinant eucaryotic vector containing allergen gene and use of preventing and treating allergic disease thereof |
JP3859270B2 (en) * | 1996-07-26 | 2006-12-20 | 森永乳業株式会社 | Apoptosis inducer |
AU747385C (en) * | 1997-04-10 | 2003-01-30 | Agennix, Inc. | Use of lactoferin in the treatment of allergen induced disorders |
EP1053243B1 (en) * | 1998-02-12 | 2011-03-30 | Emory University | Sphingolipid derivatives and their methods of use |
-
2001
- 2001-01-12 JP JP2001551502A patent/JP4787445B2/en not_active Expired - Fee Related
- 2001-01-12 NZ NZ519957A patent/NZ519957A/en unknown
- 2001-01-12 CN CNB2004100577068A patent/CN100384472C/en not_active Expired - Lifetime
- 2001-01-12 WO PCT/JP2001/000161 patent/WO2001051079A1/en active IP Right Grant
- 2001-01-12 AU AU25515/01A patent/AU782539B2/en not_active Ceased
- 2001-01-12 CN CNB018036775A patent/CN1205998C/en not_active Expired - Lifetime
-
2005
- 2005-10-06 HK HK05108838A patent/HK1076735A1/en not_active IP Right Cessation
Also Published As
Publication number | Publication date |
---|---|
NZ519957A (en) | 2003-08-29 |
JP4787445B2 (en) | 2011-10-05 |
CN1395490A (en) | 2003-02-05 |
WO2001051079A1 (en) | 2001-07-19 |
CN100384472C (en) | 2008-04-30 |
AU2551501A (en) | 2001-07-24 |
CN1626240A (en) | 2005-06-15 |
CN1205998C (en) | 2005-06-15 |
AU782539B2 (en) | 2005-08-04 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AU1593001A (en) | Recombinant gelatin in vaccines | |
WO2000061772A3 (en) | Compositions and methods for generating an immune response utilizing alphavirus-based vector systems | |
AU2002322211A1 (en) | Methods and compisitions for activation human t cells in vitro | |
AU2008243079A1 (en) | Compositions and methods for generating an immune response | |
WO2002018572A3 (en) | Membrane penetrating peptides and uses thereof | |
AU2001249380A1 (en) | Compositions and methods for generating an immune response utilizing alphavirus-based vector systems | |
AU3227700A (en) | Skin sanitizing compositions | |
NO20031159D0 (en) | Lactic acid bacteria capable of reducing an individual's tendency to develop allergic reactions | |
WO2003010288A3 (en) | Yeast expression systems, methods of producing polypeptides in yeast, and compositions relating to same | |
WO2003010291A3 (en) | Treatment of immune disorders and b cell disorders | |
NO20044898L (en) | New etonogestrel esters | |
AU1074902A (en) | Kahalalide f | |
AU2002309486A1 (en) | Methods and compositions for modulating the immune system of animals | |
PT1213974E (en) | DIRECTLY COMPRESSIVE BRIGHT SUBSTANCE FOR TABLETS | |
AU2002256347A1 (en) | Compositions and methods for the identification of protein interactions in vertebrate cells | |
HK1076735A1 (en) | Antigen-specific ige antibody production inhibitors | |
BG100248A (en) | Squalene synthetase inhibitors | |
AU2002365269A1 (en) | Mut-il-18 or mut-il-18r proteins, antibodies, compositions, methods and uses | |
MY127675A (en) | Substituted 3-pyridyl-4-arylpyrroles, and related therapeutic and prophylactic methods | |
AU2003276844A1 (en) | Formulations of modified antibodies and methods of making the same | |
WO2001034806A3 (en) | Methods and compositions for screening using diphtheria toxin constructs | |
AU2002258525A1 (en) | Telomerase expression repressor proteins and methods of using the same | |
AU2003239151A1 (en) | Compositions and methods for the acceleration of protein secretion dynamics | |
AU2002345743A1 (en) | Telomerase expression repressor proteins and methods of using the same | |
AU2002311620A1 (en) | Methods of making and using expression constructs for the expression of recombinant proteins |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PC | Patent ceased (i.e. patent has lapsed due to the failure to pay the renewal fee) |
Effective date: 20130112 |